The following data is part of a premarket notification filed by Alcresta Therapeutics, Inc. with the FDA for Relizorb.
Device ID | K161247 |
510k Number | K161247 |
Device Name: | Relizorb |
Classification | Enzyme Packed Cartridge |
Applicant | Alcresta Therapeutics, Inc. One Newton Executive Park, Suite 102 Newton, MA 02462 |
Contact | Robert Gallotto |
Correspondent | Nandini Murthy Alcresta Therapeutics, Inc. One Newton Executive Park, Suite 102 Newton, MA 02462 |
Product Code | PLQ |
CFR Regulation Number | 876.5985 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2016-05-03 |
Decision Date | 2016-06-30 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() RELIZORB 86690981 5087672 Live/Registered |
ALCRESTA THERAPEUTICS, INC. 2015-07-13 |